ADIPOQ and metabolic dysfunction-associated steatotic liver disease: For NAFLD, hepatic adipose tissue may facilitate the secretion of some inflammatory cytokines (like tumor necrosis factor‐α and interleukin 6), reduce adiponectin levels, and then cause insulin resistance.43